- Home
- TTEC vs TLSI Comparison
TTEC vs TLSI Comparison
Compare TTEC & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTEC
- TLSI
- Stock Information
- Founded
- TTEC 1982
- TLSI 2010
- Country
- TTEC United States
- TLSI United States
- Employees
- TTEC N/A
- TLSI N/A
- Industry
- TTEC Retail: Computer Software & Peripheral Equipment
- TLSI Medical Specialities
- Sector
- TTEC Technology
- TLSI Health Care
- Exchange
- TTEC Nasdaq
- TLSI Nasdaq
- Market Cap
- TTEC 190.4M
- TLSI 158.0M
- IPO Year
- TTEC 1996
- TLSI N/A
- Fundamental
- Price
- TTEC $3.86
- TLSI $5.77
- Analyst Decision
- TTEC Buy
- TLSI Strong Buy
- Analyst Count
- TTEC 5
- TLSI 6
- Target Price
- TTEC $11.17
- TLSI $11.75
- AVG Volume (30 Days)
- TTEC 252.4K
- TLSI 40.4K
- Earning Date
- TTEC 02-27-2025
- TLSI 03-27-2025
- Dividend Yield
- TTEC 1.55%
- TLSI N/A
- EPS Growth
- TTEC N/A
- TLSI N/A
- EPS
- TTEC N/A
- TLSI N/A
- Revenue
- TTEC $2,266,331,000.00
- TLSI $26,891,000.00
- Revenue This Year
- TTEC N/A
- TLSI $61.29
- Revenue Next Year
- TTEC N/A
- TLSI $53.21
- P/E Ratio
- TTEC N/A
- TLSI N/A
- Revenue Growth
- TTEC N/A
- TLSI 67.90
- 52 Week Low
- TTEC $3.37
- TLSI $3.50
- 52 Week High
- TTEC $18.44
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- TTEC 52.35
- TLSI 68.94
- Support Level
- TTEC $3.40
- TLSI $5.40
- Resistance Level
- TTEC $3.90
- TLSI $5.82
- Average True Range (ATR)
- TTEC 0.15
- TLSI 0.24
- MACD
- TTEC 0.08
- TLSI 0.01
- Stochastic Oscillator
- TTEC 79.03
- TLSI 89.19
About TTEC TTEC Holdings Inc.
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.